Henan Lingrui Pharmaceutical Co Ltd Net Asset Momentum
Henan Lingrui Pharmaceutical Co Ltd net asset momentum. Henan Lingrui Pharmaceutical Co Ltd (600285) recorded a net asset momentum of 11.5% as of December 2025, with net assets of CN¥3.44 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore reinvestment intensity of Henan Lingrui Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
Net asset momentum of Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025. This chart tracks Henan Lingrui Pharmaceutical Co Ltd's year-over-year net asset growth across 29 annual reporting periods from 1997 to 2025. The most recent momentum reading is +11.5%, with net assets of CN¥3.44 Billion CNY as of December 2025. See Henan Lingrui Pharmaceutical Co Ltd (600285) net assets for net asset value and shareholders' equity analysis.
Henan Lingrui Pharmaceutical Co Ltd Net Asset Momentum by Year (1997–2025)
Henan Lingrui Pharmaceutical Co Ltd net asset momentum by year from 1997 to 2025. The table below shows the complete annual net asset history for Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025, covering 29 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 600285 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥3.44 Billion | CN¥5.64 Billion | CN¥2.20 Billion | ▲ +11.5% |
| 2024 | CN¥3.08 Billion | CN¥5.02 Billion | CN¥1.94 Billion | ▲ +10.1% |
| 2023 | CN¥2.80 Billion | CN¥4.77 Billion | CN¥1.97 Billion | ▲ +9.4% |
| 2022 | CN¥2.56 Billion | CN¥4.34 Billion | CN¥1.79 Billion | ▲ +11.9% |
| 2021 | CN¥2.29 Billion | CN¥3.79 Billion | CN¥1.51 Billion | ▼ -1.5% |
| 2020 | CN¥2.32 Billion | CN¥3.46 Billion | CN¥1.14 Billion | ▲ +4.6% |
| 2019 | CN¥2.22 Billion | CN¥3.32 Billion | CN¥1.10 Billion | ▲ +6.0% |
| 2018 | CN¥2.09 Billion | CN¥3.11 Billion | CN¥1.02 Billion | ▼ -5.0% |
| 2017 | CN¥2.20 Billion | CN¥3.31 Billion | CN¥1.10 Billion | ▲ +4.3% |
| 2016 | CN¥2.11 Billion | CN¥2.98 Billion | CN¥869.35 Million | ▲ +22.5% |
| 2015 | CN¥1.72 Billion | CN¥2.71 Billion | CN¥984.58 Million | ▲ +10.5% |
| 2014 | CN¥1.56 Billion | CN¥2.47 Billion | CN¥913.70 Million | ▲ +58.5% |
| 2013 | CN¥984.89 Million | CN¥1.65 Billion | CN¥663.24 Million | ▲ +41.3% |
| 2012 | CN¥696.97 Million | CN¥1.29 Billion | CN¥597.36 Million | ▲ +1.9% |
| 2011 | CN¥684.01 Million | CN¥1.21 Billion | CN¥524.02 Million | ▼ -3.6% |
| 2010 | CN¥709.69 Million | CN¥1.20 Billion | CN¥489.25 Million | ▲ +9.9% |
| 2009 | CN¥645.69 Million | CN¥1.02 Billion | CN¥378.52 Million | ▲ +17.5% |
| 2008 | CN¥549.72 Million | CN¥968.27 Million | CN¥418.55 Million | ▼ -5.1% |
| 2007 | CN¥579.24 Million | CN¥942.55 Million | CN¥363.31 Million | ▲ +19.0% |
| 2006 | CN¥486.67 Million | CN¥878.69 Million | CN¥392.03 Million | ▲ +1.4% |
| 2005 | CN¥479.80 Million | CN¥872.24 Million | CN¥392.44 Million | ▲ +2.2% |
| 2004 | CN¥469.45 Million | CN¥828.81 Million | CN¥359.36 Million | ▲ +3.9% |
| 2003 | CN¥451.69 Million | CN¥741.34 Million | CN¥289.65 Million | ▲ +8.4% |
| 2002 | CN¥416.74 Million | CN¥697.75 Million | CN¥281.00 Million | ▲ +3.7% |
| 2001 | CN¥401.79 Million | CN¥560.38 Million | CN¥158.59 Million | ▼ -1.6% |
| 2000 | CN¥408.46 Million | CN¥514.79 Million | CN¥106.33 Million | ▲ +557.9% |
| 1999 | CN¥62.08 Million | CN¥175.02 Million | CN¥112.94 Million | ▲ +24.5% |
| 1998 | CN¥49.85 Million | CN¥125.63 Million | CN¥75.78 Million | ▲ +46.7% |
| 1997 | CN¥33.98 Million | CN¥89.69 Million | CN¥55.71 Million | — |